Position in ARVN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$387,786
-$106,863 QoQ
Shares Held
46,665
0.0% QoQ
Ownership
0.071%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#89
of 201 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Yelin Lapidot Holdings Management Ltd. holds $14,212,826 across 5 Biotechnology names. ARVN ranks #5 (2.7% of the industry book) .
All Filings in ARVN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $387,786 | 46,665 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $494,649 | 46,665 | Shares | Defined | 2026-04-22 | |
| 2025-12-31 | $553,446 | 46,665 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $397,585 | 46,665 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $343,454 | 46,665 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $327,588 | 46,665 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $898,555 | 46,873 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $1,219,258 | 49,503 | Shares | Defined | 2024-10-15 | |
| 2024-06-30 | $1,317,769 | 49,503 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $2,043,483 | 49,503 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $2,037,543 | 49,503 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $972,238 | 49,503 | Shares | Defined | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||